View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Cetuximab 250, Head and Neck Tumors, Cycle 2+
Protocol-ID: 1221 V1.2 (Mini), CETU250, Head and Neck Tumors, C2+Indication(s)
- Head and Neck Tumors (Squamous Cell); ICD-10 C76.0
Links
- Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up 05/2010 [ESMO]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 02.06.2020